123 related articles for article (PubMed ID: 35703749)
21. Ten Things We Need to Do to Achieve the Goals of the End the HIV Epidemic Plan for America.
Kelly JA
J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 2(2):S94-S98. PubMed ID: 31658194
[TBL] [Abstract][Full Text] [Related]
22. How Can Progress Toward Ending the Human Immunodeficiency Virus Epidemic in the United States Be Monitored?
Mitchell KM; Maheu-Giroux M; Dimitrov D; Moore M; Hughes JP; Donnell D; Beyrer C; El-Sadr WM; Cohen MS; Boily MC
Clin Infect Dis; 2022 Aug; 75(1):163-169. PubMed ID: 34849635
[TBL] [Abstract][Full Text] [Related]
23. Enhanced Federal Collaborations in Implementation Science and Research of HIV Prevention and Treatment.
Purcell DW; Namkung Lee A; Dempsey A; Gordon C
J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S17-S22. PubMed ID: 35703751
[TBL] [Abstract][Full Text] [Related]
24. Roles for Pharmacists in the "Ending the HIV Epidemic: A Plan for America" Initiative.
McCree DH; Byrd KK; Johnston M; Gaines M; Weidle PJ
Public Health Rep; 2020; 135(5):547-554. PubMed ID: 32780671
[TBL] [Abstract][Full Text] [Related]
25. Ending the HIV Epidemic: A Plan for the United States.
Fauci AS; Redfield RR; Sigounas G; Weahkee MD; Giroir BP
JAMA; 2019 Mar; 321(9):844-845. PubMed ID: 30730529
[No Abstract] [Full Text] [Related]
26. Simulating the End of AIDS in New York: Using Participatory Dynamic Modeling to Improve Implementation of the Ending the Epidemic Initiative.
Martin EG; MacDonald RH; Gordon DE; Swain CA; O'Donnell T; Helmeset J; Dwicaksono A; Tesoriero JM
Public Health Rep; 2020; 135(1_suppl):158S-171S. PubMed ID: 32735199
[TBL] [Abstract][Full Text] [Related]
27. Moving toward equity: fostering transdisciplinary research between the social and behavioral sciences and implementation science to end the HIV epidemic.
Pyra M; Motley D; Bouris A
Curr Opin HIV AIDS; 2022 Mar; 17(2):89-99. PubMed ID: 35225249
[TBL] [Abstract][Full Text] [Related]
28. Strengthening HIV Prevention Services Through an Implementation Science Approach: Perspectives From the HIV Testers in Philadelphia.
Wood SM; Meanley S; Bonett S; Torres ME; Watson DL; Williams JL; Brady KA; Bauermeister JA
J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S90-S97. PubMed ID: 35703760
[TBL] [Abstract][Full Text] [Related]
29. The Black women first initiative: using implementation science to examine bundled interventions to improve care and treatment coordination for Black women with HIV.
Rajabiun S; Heath C; Walter AW; Scott JC; Downes A; Jennings E; Cabral HJ; Flores-Rodriguez C; Sprague Martinez L
BMC Health Serv Res; 2023 May; 23(1):551. PubMed ID: 37237372
[TBL] [Abstract][Full Text] [Related]
30. Assessing the reliability of the CD4 depletion model in the presence of Ending the HIV Epidemic initiatives.
Tang ME; Goyal R; Anderson CM; Mehta SR; Little SJ
AIDS; 2023 Aug; 37(10):1617-1624. PubMed ID: 37260256
[TBL] [Abstract][Full Text] [Related]
31. HIV Testing in 50 Local Jurisdictions Accounting for the Majority of New HIV Diagnoses and Seven States with Disproportionate Occurrence of HIV in Rural Areas, 2016-2017.
Pitasi MA; Delaney KP; Brooks JT; DiNenno EA; Johnson SD; Prejean J
MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(25):561-567. PubMed ID: 31246940
[TBL] [Abstract][Full Text] [Related]
32. The Broader Context of "Ending the HIV Epidemic: A Plan for America" Initiative.
Kates J; Millett G; Dawson L; Honermann B; Jones A; Sherwood J; Garcia ZI; Kuenzle K
Am J Public Health; 2020 Jan; 110(1):58-60. PubMed ID: 31800281
[No Abstract] [Full Text] [Related]
33. HIV Partner Service Delivery Among Transgender Women - United States, 2013-2017.
Song W; Mulatu MS; Rao S; Wang G; Kudon HZ; O'Connor K
MMWR Morb Mortal Wkly Rep; 2020 Jan; 69(2):35-39. PubMed ID: 31945033
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the sensitivity of jurisdictional heterogeneity and jurisdictional mixing in national level HIV prevention analyses: context of the U.S. ending the HIV epidemic plan.
Tatapudi H; Gopalappa C
BMC Med Res Methodol; 2022 Nov; 22(1):304. PubMed ID: 36435750
[TBL] [Abstract][Full Text] [Related]
35. Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men - 20 Urban Areas, 2014 and 2017.
Finlayson T; Cha S; Xia M; Trujillo L; Denson D; Prejean J; Kanny D; Wejnert C;
MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(27):597-603. PubMed ID: 31298662
[TBL] [Abstract][Full Text] [Related]
36. Is the USA on track to end the HIV epidemic?
Guilamo-Ramos V; Thimm-Kaiser M; Benzekri A
Lancet HIV; 2023 Aug; 10(8):e552-e556. PubMed ID: 37541707
[TBL] [Abstract][Full Text] [Related]
37. Importance of rigorous implementation science studies to scale-up evidence-based interventions to end the HIV epidemic in the United States.
Joseph Davey DL; de Villiers L; Evens E
AIDS; 2021 Feb; 35(2):335-336. PubMed ID: 33394674
[No Abstract] [Full Text] [Related]
38. HIV Preexposure Prophylaxis Awareness and Referral to Providers Among Hispanic/Latino Persons - United States, 2019.
Rao S; Mulatu MS; Xia M; Wang G; Song W; Essuon A; Patel D; Eke A; German EJ;
MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(40):1395-1400. PubMed ID: 34618795
[TBL] [Abstract][Full Text] [Related]
39. Implementation of Evidence-Informed Behavioral Health Models to Improve HIV Health Outcomes for Black Men Who Have Sex With Men (Black MSM Initiative): Protocol for Program Evaluation.
Hodge SE; Johnson-Turbes A; Flemming SSC; Passero M; Tinsley M; Iheanyichukwu T;
JMIR Res Protoc; 2022 Jul; 11(7):e36025. PubMed ID: 35877157
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
